We also aim at giving a comprehensive overview of the therapeutic strategies presently available to counteract PCSK9 activity; in particular, we discuss their application in the AD treatment and evaluate their possible capability to specifically affect PCSK9 functions inside the brain. Here, PCSK9 is linked to Alzheimer disease.